Source: Outsourcing-Pharma

Sagent Pharmaceuticals: Sagent issues voluntary recall of phenylephrine hydrochloride vials

The company is recalling 10 mg/mL vials of phenylephrine hydrochloride due to potential lack of sterility assurance in several lots of the product.

Read full article »
Sagent Pharmaceuticals's Competitors | Sagent Pharmaceuticals's News | Sagent Pharmaceuticals's Financials
Stay up-to-date with the latest news on Sagent
Est. Annual Revenue
$100-500M
Est. Employees
250-500
Peter Kaemmerer's photo - CEO of Sagent

CEO

Peter Kaemmerer

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on Sagent